Vascular damage in patients with nonalcoholic fatty liver disease

Possible role of iron and ferritin

Giuseppina Pisano, Rosa Lombardi, Anna Ludovica Fracanzani

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countries. Recent data indicated that NAFLD is a risk factor by itself contributing to the development of cardiovascular disease independently of classical known risk factors. Hyperferritinemia and mild increased iron stores are frequently observed in patients with NAFLD and several mechanisms have been proposed to explain the role of iron, through oxidative stress and interaction with insulin metabolism, in the development of vascular damage. Moreover, iron depletion has been shown to decrease atherogenesis in experimental models and in humans. This review presents the recent evidence on epidemiology, pathogenesis, and the possible explanation of the role of iron and ferritin in the development of cardiovascular damage in patients with NAFLD, and discusses the possible interplay between metabolic disorders associated with NAFLD and iron in the development of cardiovascular disease.

Original languageEnglish
Article number675
JournalInternational Journal of Molecular Sciences
Volume17
Issue number5
DOIs
Publication statusPublished - May 5 2016

Fingerprint

Ferritins
liver
Liver
Blood Vessels
Iron
damage
iron
Cardiovascular Diseases
epidemiology
Liver Diseases
Atherosclerosis
Epidemiology
Oxidative Stress
Chronic Disease
Theoretical Models
pathogenesis
insulin
Oxidative stress
Non-alcoholic Fatty Liver Disease
Insulin

Keywords

  • Cardiovascular disease
  • Ferritin
  • Iron
  • Metabolic syndrome
  • NAFLD

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

Vascular damage in patients with nonalcoholic fatty liver disease : Possible role of iron and ferritin. / Pisano, Giuseppina; Lombardi, Rosa; Fracanzani, Anna Ludovica.

In: International Journal of Molecular Sciences, Vol. 17, No. 5, 675, 05.05.2016.

Research output: Contribution to journalArticle

@article{3d8c6e83f720409ab770dcc9d6f4971b,
title = "Vascular damage in patients with nonalcoholic fatty liver disease: Possible role of iron and ferritin",
abstract = "Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countries. Recent data indicated that NAFLD is a risk factor by itself contributing to the development of cardiovascular disease independently of classical known risk factors. Hyperferritinemia and mild increased iron stores are frequently observed in patients with NAFLD and several mechanisms have been proposed to explain the role of iron, through oxidative stress and interaction with insulin metabolism, in the development of vascular damage. Moreover, iron depletion has been shown to decrease atherogenesis in experimental models and in humans. This review presents the recent evidence on epidemiology, pathogenesis, and the possible explanation of the role of iron and ferritin in the development of cardiovascular damage in patients with NAFLD, and discusses the possible interplay between metabolic disorders associated with NAFLD and iron in the development of cardiovascular disease.",
keywords = "Cardiovascular disease, Ferritin, Iron, Metabolic syndrome, NAFLD",
author = "Giuseppina Pisano and Rosa Lombardi and Fracanzani, {Anna Ludovica}",
year = "2016",
month = "5",
day = "5",
doi = "10.3390/ijms17050675",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "5",

}

TY - JOUR

T1 - Vascular damage in patients with nonalcoholic fatty liver disease

T2 - Possible role of iron and ferritin

AU - Pisano, Giuseppina

AU - Lombardi, Rosa

AU - Fracanzani, Anna Ludovica

PY - 2016/5/5

Y1 - 2016/5/5

N2 - Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countries. Recent data indicated that NAFLD is a risk factor by itself contributing to the development of cardiovascular disease independently of classical known risk factors. Hyperferritinemia and mild increased iron stores are frequently observed in patients with NAFLD and several mechanisms have been proposed to explain the role of iron, through oxidative stress and interaction with insulin metabolism, in the development of vascular damage. Moreover, iron depletion has been shown to decrease atherogenesis in experimental models and in humans. This review presents the recent evidence on epidemiology, pathogenesis, and the possible explanation of the role of iron and ferritin in the development of cardiovascular damage in patients with NAFLD, and discusses the possible interplay between metabolic disorders associated with NAFLD and iron in the development of cardiovascular disease.

AB - Non Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in Western countries. Recent data indicated that NAFLD is a risk factor by itself contributing to the development of cardiovascular disease independently of classical known risk factors. Hyperferritinemia and mild increased iron stores are frequently observed in patients with NAFLD and several mechanisms have been proposed to explain the role of iron, through oxidative stress and interaction with insulin metabolism, in the development of vascular damage. Moreover, iron depletion has been shown to decrease atherogenesis in experimental models and in humans. This review presents the recent evidence on epidemiology, pathogenesis, and the possible explanation of the role of iron and ferritin in the development of cardiovascular damage in patients with NAFLD, and discusses the possible interplay between metabolic disorders associated with NAFLD and iron in the development of cardiovascular disease.

KW - Cardiovascular disease

KW - Ferritin

KW - Iron

KW - Metabolic syndrome

KW - NAFLD

UR - http://www.scopus.com/inward/record.url?scp=84965138993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965138993&partnerID=8YFLogxK

U2 - 10.3390/ijms17050675

DO - 10.3390/ijms17050675

M3 - Article

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 5

M1 - 675

ER -